Microbot Medical (MBOT) Net Margin (2016)
Historic Net Margin for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to 5775.44%.
- Microbot Medical's Net Margin rose 214797600.0% to 5775.44% in Q3 2016 from the same period last year, while for Dec 2016 it was 24179.28%, marking a year-over-year increase of 75891000.0%. This contributed to the annual value of 31842.04% for FY2015, which is N/A changed from last year.
- Latest data reveals that Microbot Medical reported Net Margin of 5775.44% as of Q3 2016, which was up 214797600.0% from 30295.83% recorded in Q2 2016.
- Microbot Medical's 5-year Net Margin high stood at 12.57% for Q4 2014, and its period low was 43550.75% during Q1 2015.
- In the last 5 years, Microbot Medical's Net Margin had a median value of 1926.61% in 2012 and averaged 11583.22%.
- Its Net Margin has fluctuated over the past 5 years, first crashed by -433090900bps in 2015, then skyrocketed by 214797600bps in 2016.
- Over the past 5 years, Microbot Medical's Net Margin (Quarter) stood at 2919.28% in 2012, then surged by 91bps to 255.56% in 2013, then surged by 95bps to 12.57% in 2014, then plummeted by -234860bps to 29536.33% in 2015, then skyrocketed by 80bps to 5775.44% in 2016.
- Its Net Margin stands at 5775.44% for Q3 2016, versus 30295.83% for Q2 2016 and 42469.06% for Q1 2016.